| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/01/2006 | US7083797 32-kDa protein derived from Mycobacterium tuberculosis and related peptides |
| 08/01/2006 | US7083796 Fusion proteins of mycobacterium tuberculosis |
| 08/01/2006 | US7083793 Coding Mycobacterium tuberculosis; isolation protein |
| 08/01/2006 | US7083792 Immunologically active proteins from Borrelia burgdorferi |
| 08/01/2006 | US7083791 Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides |
| 08/01/2006 | US7083789 Polynucleotides; induce lymphocyte response |
| 08/01/2006 | US7083788 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 08/01/2006 | US7083785 Tumor necrosis factor family and its blocking agent |
| 08/01/2006 | US7083784 Molecules with extended half-lives, compositions and uses thereof |
| 08/01/2006 | CA2307061C Process for separating and recovering protein and isoflavones from a plant material |
| 08/01/2006 | CA2265485C Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 08/01/2006 | CA2257867C Editing-based selectable plastid marker genes |
| 08/01/2006 | CA2165435C Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 07/27/2006 | WO2006078824A2 Eggshell membrane separation method |
| 07/27/2006 | WO2006078746A2 Method, compositions and classification for tumor diagnostics and treatment |
| 07/27/2006 | WO2006078733A2 Estrogen receptor structure |
| 07/27/2006 | WO2006078274A2 Beta-peptides |
| 07/27/2006 | WO2006078268A2 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 07/27/2006 | WO2006078161A1 Binding compounds, immunogenic compounds and peptidomimetics |
| 07/27/2006 | WO2006078059A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | WO2006078039A1 L-amino acid producing microorganism and a method for producing l-amino acid |
| 07/27/2006 | WO2006077736A1 Gene participating in silicon absorption and utilization of the same |
| 07/27/2006 | WO2006077675A1 Fibrosis inhibitor for implanted organ |
| 07/27/2006 | WO2006077448A1 Modified flagellins and flagellar filaments useful as receptors and methods for the preparation thereof |
| 07/27/2006 | WO2006077442A2 Inhibition of islet amyloid polypeptide (iapp) aggregation for the treatment of type 2 diabetes |
| 07/27/2006 | WO2006077441A1 Specific binding members for ngf |
| 07/27/2006 | WO2006077404A2 Cell adhesion by modified cadherin molecules |
| 07/27/2006 | WO2006077152A2 Hla fusion molecules and uses thereof |
| 07/27/2006 | WO2006077126A2 Cx3cr1 as a marker which correlates with both disease and disease activity in multiple sclerosis patients |
| 07/27/2006 | WO2006077101A2 Ager-peptides and use thereof |
| 07/27/2006 | WO2006077035A1 Peptides with neuropeptide-2 receptor (y2r) agonist activity |
| 07/27/2006 | WO2006076965A1 R-hydroxynitrile lyases having improved substrate acceptance and the use thereof |
| 07/27/2006 | WO2006058359A3 Protein allergen derivatives |
| 07/27/2006 | WO2006051313A3 Peptides designed to switch folded state upon binding metals |
| 07/27/2006 | WO2006050041A3 Methods for reducing or inhibiting brain inflammation or for promoting neurogenesis |
| 07/27/2006 | WO2006047684A3 Tissue factor phospholipid vesicle particles and methods of use for coagulation |
| 07/27/2006 | WO2006042661A3 Oligopeptides and their use in cosmetics |
| 07/27/2006 | WO2006040312A3 Fungal transcriptional activators useful in methods for producing a polypeptide |
| 07/27/2006 | WO2006039592A9 Use of il-17- for maturation of oocytes |
| 07/27/2006 | WO2006037807A3 Identification of regions of apical membrane antigen 1 of apicomplexan parasites suitable for targeting by vaccines and drugs by derivation and analysis of the three-dimensional structure |
| 07/27/2006 | WO2006031363A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/27/2006 | WO2006014798A3 Methods and compositions for using sax2 |
| 07/27/2006 | WO2006008128A3 Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders |
| 07/27/2006 | WO2005114206A3 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a) |
| 07/27/2006 | WO2005113589A3 Modified antigen-presenting cells |
| 07/27/2006 | WO2005111078A3 Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept |
| 07/27/2006 | WO2005110459A3 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 07/27/2006 | WO2005110056A3 Compositions comprising addl receptor syngap |
| 07/27/2006 | WO2005102038A3 Expression of polypeptides in rod outer segment membranes |
| 07/27/2006 | WO2005100381A3 Processes for preparing eptifibatide and pertinent intermediate compounds |
| 07/27/2006 | WO2005092922A3 Antigen of the pm-2 antibody and use thereof |
| 07/27/2006 | WO2005086813A3 Glutamine-rich maize seed protein and promoter |
| 07/27/2006 | WO2005082005A3 Positive modulator of bone morphogenic protein-2 |
| 07/27/2006 | WO2005060675A3 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 07/27/2006 | WO2005002516A9 Leukocyte internalized peptide-drug conjugates |
| 07/27/2006 | WO2004091517A3 Conjugates comprising human il-18 and substitution mutants thereof |
| 07/27/2006 | WO2004053081A3 Compositions, splice variants and methods relating to prostate specific genes and proteins |
| 07/27/2006 | WO2004039948A3 Actriib fusion polypeptides and uses therefor |
| 07/27/2006 | WO2004034988A3 Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors |
| 07/27/2006 | WO2004024890A3 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 07/27/2006 | WO2003085086A3 Motif-grafted hybrid polypeptides and uses thereof |
| 07/27/2006 | US20060168700 Expression of the dicamba-degrading enzymes results in the production of dicamba-degrading organisms, including dicamba-tolerant plants |
| 07/27/2006 | US20060168697 Transporters and their uses |
| 07/27/2006 | US20060168695 Transgenic bacteria, plant, cells, cell cultures, parts, tissues, organs or propagation materials; targeted transgenic expression of nucleic acid sequences |
| 07/27/2006 | US20060168693 Transforming plant with a DNA construct comprising a promoter that functions in plants, operably linked to a DNA molecule that encodes a protein, wherein promoter is heterologous to the DNA molecule; transgenic plants |
| 07/27/2006 | US20060168691 Plants which synthesize a modified starch, process for the production thereof and modified starch |
| 07/27/2006 | US20060168688 Triacylglycerol lipases |
| 07/27/2006 | US20060168686 introducing into progenitor cells of the plant a plant transformation vector comprising a heterologous constitutive promoter operatively linked to a nucleotide sequence that encodes a HIO32.2 polypeptide, growing the cell to produce transgenic plant with an altered oil content phenotype |
| 07/27/2006 | US20060168685 introducing into progenitor cells of the plant a plant transformation vector comprising a heterologous constitutive promoter operatively linked to a nucleotide sequence that encodes a HIO32.2 polypeptide, growing the cell to produce transgenic plant with an altered oil content phenotype |
| 07/27/2006 | US20060168683 Insecticidal toxin complex fusion proteins |
| 07/27/2006 | US20060168682 Plant peptide with antimicrobial activity |
| 07/27/2006 | US20060168676 Novel inducible genes from alfalfa and methods of use thereof |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060168670 identification of new gene families that are differentially expressed in cancerous human tissues compared to normal human tissues; useful as diagnostic agents or markers to detect cancer or to differentiate carcinoma from normal tissue in a sample; nucleotide sequence |
| 07/27/2006 | US20060168667 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 07/27/2006 | US20060168666 Autoimmune disease model animal |
| 07/27/2006 | US20060168665 Flourescent proteins as cell type specific reporters |
| 07/27/2006 | US20060167238 Gene expression using metal ion dependent repressor/operator tandems |
| 07/27/2006 | US20060167234 a portion of orally administered prodrug remains in prodrug form (i.e., the oligomer remains attached), protecting the polypeptide through the digestive tract; traverses the wall of the digestive tract and enters into the blood stream; and/or converted in the system |
| 07/27/2006 | US20060167233 One-step reduction and alkylation of proteins |
| 07/27/2006 | US20060167231 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2006 | US20060167230 Anti-pci neutralizing antibody |
| 07/27/2006 | US20060167229 Biologically active peptide conjugates |
| 07/27/2006 | US20060167228 Sequences from an endosymbiont and their uses |
| 07/27/2006 | US20060167227 Truncated tau proteins |
| 07/27/2006 | US20060167226 Mutations of voltage-gated ion channnels that allow them to express a voltage-independent phenotype and an improved method to use the same |
| 07/27/2006 | US20060167225 Novel fluorescent protein from aequorea coerulscens and methods for using the same |
| 07/27/2006 | US20060167224 Novel functional peptide nucleic acid and process for producing the same |
| 07/27/2006 | US20060167221 Process for the extraction and isolation of insulin from recombinant sources |
| 07/27/2006 | US20060167220 Methods and compositions for preparing peptides with excellent solubility characteristics in aqueous solution at physiological pH |
| 07/27/2006 | US20060166915 Human coagulation factor VII polypeptides |
| 07/27/2006 | US20060166914 Method of nucleic acid infusion |
| 07/27/2006 | US20060166910 Rna-interference by single-stranded rna molecules |
| 07/27/2006 | US20060166895 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 07/27/2006 | US20060166892 Treatment of cell proliferative disorders with chlorotoxin |
| 07/27/2006 | US20060166891 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 07/27/2006 | US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes |
| 07/27/2006 | US20060166881 Membrane-permeant peptide complexes for treatment of sepsis |
| 07/27/2006 | US20060166880 Control a mechanism of intracellular release of calcium, to control signal transmission in which intracellular calcium is involved; to control intracellular calcium release by carbonic anhydrase-related protein (CARP), to regulate or diagnose activity of IP3R |
| 07/27/2006 | US20060166878 treating a disease or disorder/condition associated with VEGF-induced neovascularization or angiogenesis; for topical application to the skin or to the eye |